Cargando…

Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura

Neurological symptoms related to microthrombosis are the hallmark of acute manifestations of acquired thrombotic thrombocytopenic purpura (TTP). Despite the achievement of hematological remission, patients may report persisting neurological impairment that affects their quality of life. To assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Silvia, Mancini, Ilaria, Maino, Alberto, Ferrari, Barbara, Artoni, Andrea, Agosti, Pasquale, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327631/
https://www.ncbi.nlm.nih.gov/pubmed/31558667
http://dx.doi.org/10.3324/haematol.2019.226423
_version_ 1783552584301150208
author Riva, Silvia
Mancini, Ilaria
Maino, Alberto
Ferrari, Barbara
Artoni, Andrea
Agosti, Pasquale
Peyvandi, Flora
author_facet Riva, Silvia
Mancini, Ilaria
Maino, Alberto
Ferrari, Barbara
Artoni, Andrea
Agosti, Pasquale
Peyvandi, Flora
author_sort Riva, Silvia
collection PubMed
description Neurological symptoms related to microthrombosis are the hallmark of acute manifestations of acquired thrombotic thrombocytopenic purpura (TTP). Despite the achievement of hematological remission, patients may report persisting neurological impairment that affects their quality of life. To assess the long-term neuropsychological consequences of acute TTP, we recruited 35 acquired TTP patients (77% females, median age at onset 41 years, interquartile range: 35–48) regularly followed at our out-patient clinic of thrombotic microangiopathies in Milan (Italy) from December 2015 to October 2016. Patients underwent a psychological evaluation of memory and attentional functions, emotional wellbeing and health-related quality of life at least three months after their last acute TTP event (median 36 months, interquartile range: 17–54). During the psychological consultation, 17 patients (49%) referred persisting subjective neurological impairment in the frame of a remission phase, with at least one symptom as disorientation, loss of concentration, dizziness, lack of balance, headache and diplopia. Neuropsychological assessment revealed lower scores than the Italian general population pertaining to direct, indirect and deferred memory. A higher degree of impairment of memory domains was found in patients with neurological involvement at the time of presentation of the first acute TTP episode. Anxiety and depression were detected in seven (20%) and 15 (43%) patients, respectively. Health-related quality of life was lower than the Italian general population, with mental domains more impacted than physical domains (mean difference 58.43, 95% confidence interval: 71.49–45.37). Our study demonstrates compromised memory and attention functions, persisting anxiety/depression symptoms and a generally reduced quality of life in patients recovering from acute acquired TTP. New clinical strategies should be considered to improve these symptoms.
format Online
Article
Text
id pubmed-7327631
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ferrata Storti Foundation
record_format MEDLINE/PubMed
spelling pubmed-73276312020-07-10 Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura Riva, Silvia Mancini, Ilaria Maino, Alberto Ferrari, Barbara Artoni, Andrea Agosti, Pasquale Peyvandi, Flora Haematologica Articles Neurological symptoms related to microthrombosis are the hallmark of acute manifestations of acquired thrombotic thrombocytopenic purpura (TTP). Despite the achievement of hematological remission, patients may report persisting neurological impairment that affects their quality of life. To assess the long-term neuropsychological consequences of acute TTP, we recruited 35 acquired TTP patients (77% females, median age at onset 41 years, interquartile range: 35–48) regularly followed at our out-patient clinic of thrombotic microangiopathies in Milan (Italy) from December 2015 to October 2016. Patients underwent a psychological evaluation of memory and attentional functions, emotional wellbeing and health-related quality of life at least three months after their last acute TTP event (median 36 months, interquartile range: 17–54). During the psychological consultation, 17 patients (49%) referred persisting subjective neurological impairment in the frame of a remission phase, with at least one symptom as disorientation, loss of concentration, dizziness, lack of balance, headache and diplopia. Neuropsychological assessment revealed lower scores than the Italian general population pertaining to direct, indirect and deferred memory. A higher degree of impairment of memory domains was found in patients with neurological involvement at the time of presentation of the first acute TTP episode. Anxiety and depression were detected in seven (20%) and 15 (43%) patients, respectively. Health-related quality of life was lower than the Italian general population, with mental domains more impacted than physical domains (mean difference 58.43, 95% confidence interval: 71.49–45.37). Our study demonstrates compromised memory and attention functions, persisting anxiety/depression symptoms and a generally reduced quality of life in patients recovering from acute acquired TTP. New clinical strategies should be considered to improve these symptoms. Ferrata Storti Foundation 2020-07 /pmc/articles/PMC7327631/ /pubmed/31558667 http://dx.doi.org/10.3324/haematol.2019.226423 Text en Copyright© 2020 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
spellingShingle Articles
Riva, Silvia
Mancini, Ilaria
Maino, Alberto
Ferrari, Barbara
Artoni, Andrea
Agosti, Pasquale
Peyvandi, Flora
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title_full Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title_fullStr Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title_full_unstemmed Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title_short Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
title_sort long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327631/
https://www.ncbi.nlm.nih.gov/pubmed/31558667
http://dx.doi.org/10.3324/haematol.2019.226423
work_keys_str_mv AT rivasilvia longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT manciniilaria longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT mainoalberto longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT ferraribarbara longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT artoniandrea longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT agostipasquale longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura
AT peyvandiflora longtermneuropsychologicalsequelaeemotionalwellbeingandqualityoflifeinpatientswithacquiredthromboticthrombocytopenicpurpura